Madrigal Pharmaceuticals, Inc. (MDGL) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Madrigal Pharmaceuticals, Inc. (MDGL) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

MDGL Income Statement

Madrigal Pharmaceuticals, Inc. (MDGL) annual income statement — 23-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	431.27M	364.25M	311.34M	321.08M	287.27M	212.8M	137.25M	103.32M	62.17M	14.64M	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	50.13%	71.17%	126.84%	210.77%	362.03%	1353.76%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	37.81M	40.01M	26.85M	24.45M	18.12M	9.06M	4.51M	3.44M	2.15M	636K	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	8.77%	10.98%	8.62%	7.61%	6.31%	4.26%	3.29%	3.33%	3.46%	4.34%	-	-	-	-	-	-	-	-	-	-
Gross Profit	393.45M	324.25M	284.49M	296.63M	269.15M	203.74M	132.74M	99.88M	60.02M	14M	0	0	0	0	0	0	0	0	0	0
Gross Margin %	91.23%	89.02%	91.38%	92.39%	93.69%	95.74%	96.71%	96.67%	96.54%	95.66%	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	46.19%	59.15%	114.33%	197.01%	348.4%	1355.06%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	337.46M	380.55M	377.21M	356.24M	383.12M	250.94M	212.05M	166.87M	176.33M	176.54M	152.04M	117.18M	98.53M	86.45M	78.34M	85.3M	80.41M	70.27M	57.59M	64.6M
OpEx % of Revenue	78.25%	104.48%	121.16%	110.95%	133.37%	117.92%	154.5%	161.51%	283.6%	1206.03%	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	265.71M	289.38M	268.52M	239.98M	209.12M	196.86M	167.88M	141.22M	107.58M	105.45M	80.8M	46.54M	27.58M	17.84M	16.18M	14.56M	12.14M	11.77M	9.66M	11.71M
SG&A % of Revenue	61.61%	79.44%	86.25%	74.74%	72.8%	92.51%	122.31%	136.69%	173.04%	720.37%	-	-	-	-	-	-	-	-	-	-
Research & Development	71.75M	91.18M	108.69M	116.27M	174M	54.08M	44.17M	25.65M	68.74M	71.09M	71.24M	70.64M	70.95M	68.61M	62.15M	70.74M	68.27M	58.5M	47.93M	52.89M
R&D % of Revenue	16.64%	25.03%	34.91%	36.21%	60.57%	25.41%	32.18%	24.82%	110.56%	485.66%	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	55.99M	-56.31M	-92.72M	-59.61M	-113.97M	-47.2M	-79.31M	-67M	-116.3M	-162.54M	-152.04M	-117.18M	-98.53M	-86.45M	-78.34M	-85.3M	-80.41M	-70.27M	-57.59M	-64.6M
Operating Margin %	12.98%	-15.46%	-29.78%	-18.57%	-39.68%	-22.18%	-57.79%	-64.84%	-187.06%	-1110.38%	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	149.12%	-19.29%	-16.91%	11.03%	2%	70.96%	47.83%	42.82%	-18.03%	-88.01%	-94.08%	-37.37%	-22.54%	-23.02%	-36.03%	-32.04%	-27.31%	-13.82%	-8.7%	-8.47%
EBITDA	56.38M	-55.93M	-92.34M	-59.22M	-113.62M	-46.83M	-78.93M	-66.63M	-116.01M	-162.27M	-151.87M	-117.03M	-98.4M	-86.32M	-78.21M	-85.17M	-80.29M	-70.16M	-57.48M	-64.5M
EBITDA Margin %	13.07%	-15.35%	-29.66%	-18.44%	-39.55%	-22%	-57.51%	-64.49%	-186.58%	-1108.55%	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	149.62%	-19.44%	-16.98%	11.13%	2.06%	71.14%	48.03%	43.07%	-17.89%	-87.98%	-94.18%	-37.41%	-22.55%	-23.03%	-36.07%	-32.06%	-27.32%	-13.8%	-8.73%	-8.51%
D&A (Non-Cash Add-back)	391K	381K	386K	392K	358K	377K	379K	363K	298K	267K	168K	142K	135K	126K	124K	129K	121K	110K	107K	106K
EBIT	63.51M	-50M	-86.57M	-50.28M	-106.74M	-39.02M	-69.94M	-55.92M	-103.28M	-148.31M	-143.7M	-108.22M	-95.24M	-82.9M	-74.56M	-84.22M	-79.69M	-69.95M	-57.52M	-64.6M
Net Interest Income	170K	-836K	424K	1.16M	2.86M	4.96M	6.07M	7.58M	9.34M	10.57M	4.5M	4.98M	-206K	650K	1.44M	-606K	-785K	-457K	69K	52K
Interest Income	8.24M	7.1M	8.24M	9.46M	10.31M	8.23M	9.37M	11.08M	13.02M	14.22M	8.33M	8.95M	3.3M	3.55M	3.78M	1.08M	717K	323K	69K	52K
Interest Expense	8.07M	7.94M	7.82M	8.3M	7.45M	3.26M	3.3M	3.5M	3.68M	3.66M	3.84M	3.97M	3.5M	2.9M	2.34M	1.68M	1.5M	780K	0	0
Other Income/Expense	-547K	-1.63M	-1.67M	1.03M	-215K	4.92M	6.07M	7.58M	9.34M	10.57M	4.5M	4.98M	-206K	650K	1.44M	-606K	-785K	-457K	69K	52K
Pretax Income	55.44M	-57.94M	-94.39M	-58.58M	-114.19M	-42.28M	-73.24M	-59.42M	-106.96M	-151.97M	-147.54M	-112.19M	-98.74M	-85.8M	-76.9M	-85.91M	-81.2M	-70.73M	-57.52M	-64.55M
Pretax Margin %	12.86%	-15.91%	-30.32%	-18.24%	-39.75%	-19.87%	-53.36%	-57.51%	-172.04%	-1038.2%	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	55.44M	-57.94M	-94.39M	-58.58M	-114.19M	-42.28M	-73.24M	-59.42M	-106.96M	-151.97M	-147.54M	-112.19M	-98.74M	-85.8M	-76.9M	-85.91M	-81.2M	-70.73M	-57.52M	-64.55M
Net Margin %	12.86%	-15.91%	-30.32%	-18.24%	-39.75%	-19.87%	-53.36%	-57.51%	-172.04%	-1038.2%	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	148.55%	-37.03%	-28.88%	1.42%	-6.76%	72.18%	50.36%	47.04%	-8.33%	-77.12%	-91.87%	-30.6%	-21.61%	-21.31%	-33.69%	-33.08%	-28.68%	-14.73%	-9.46%	-9.18%
Net Income (Continuing)	55.44M	-57.94M	-94.39M	-58.58M	-114.19M	-42.28M	-73.24M	-59.42M	-106.96M	-151.97M	-147.54M	-112.19M	-98.74M	-85.8M	-76.9M	-85.91M	-81.2M	-70.73M	-57.52M	-64.55M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	1.83	-1.99	-3.25	-2.57	-5.08	-1.90	-3.32	-2.71	-4.92	-7.10	-7.38	-5.68	-5.34	-4.69	-4.23	-4.98	-4.75	-4.14	-3.36	-3.78
EPS Growth %	136.02%	-4.74%	2.11%	5.17%	-3.25%	73.24%	55.01%	52.29%	7.87%	-51.39%	-74.47%	-14.06%	-12.42%	-13.29%	-25.89%	-31.75%	-25.33%	-11.29%	-1.2%	1.05%
EPS (Basic)	1.90	-1.99	-3.25	-2.57	-5.08	-1.90	-3.32	-2.71	-4.92	-7.10	-7.38	-5.68	-5.34	-4.69	-4.23	-4.98	-4.75	-4.14	-3.36	-3.78
Diluted Shares Outstanding	30.31M	29.15M	29.03M	22.43M	22.48M	22.21M	22.09M	21.93M	21.75M	21.4M	20M	19.76M	18.48M	18.31M	18.19M	17.24M	17.1M	17.1M	17.1M	17.07M
Basic Shares Outstanding	29.25M	29.15M	29.03M	22.43M	22.48M	22.21M	22.09M	21.93M	21.75M	21.4M	20M	19.76M	18.48M	18.31M	18.19M	17.24M	17.1M	17.1M	17.1M	17.07M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-